Dataset from A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008224
下载链接
链接失效反馈官方服务：
资源简介：
CALAVI US will investigate the safety, efficacy and pharmacokinetics of acalabrutinib
together with Best Supportive Care in the treatment of COVID-19.
创建时间：
2025-07-07
